Silicon: The evolution of its use in biomaterials

Acta Biomaterialia

Volumn 11, Issue 1, 2015, Pages 17-26

  Henstock, J R ^a   Canham, L T ^b   Anderson, S I ^c  

^a KEELE UNIVERSITY   (United Kingdom)

^b pSiMedica Ltd   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Biomaterial; Biomaterials; Orthosilicic acid; Silicic acid; Silicon

Indexed keywords

BIOACTIVE GLASS; BIOACTIVITY; BIOLOGICAL SYSTEMS; BONE; CRYSTAL STRUCTURE; GENE EXPRESSION; HYDROXYAPATITE; MOLECULAR BIOLOGY; OSTEOBLASTS; PROTEINS; SILICATES;

'CURRENT; BIOACTIVE MATERIAL; BIOACTIVES; BIOLOGICAL FUNCTIONS; BONE DEVELOPMENT; EXTRACELLULAR MATRICES; ORTHOSILICIC ACID; SEPARATE EFFECTS; SILICATE GLASS; SILICIC ACIDS;

SILICON;

ALUMINUM; BIOMATERIAL; CALCIUM OXIDE; GLYCOSAMINOGLYCAN; HYDROXYAPATITE; HYDROXYL GROUP; SCLEROPROTEIN; SILICA NANOPARTICLE; SILICATE; SILICIC ACID; SILICON; SILICON DIOXIDE; BONE PROSTHESIS; DIFFERENTIATION ANTIGEN; GLASS;

BIOCHEMISTRY; BONE DENSITY; BONE DEVELOPMENT; BONE MINERAL; EXTRACELLULAR MATRIX; GEL; HUMAN; OSTEOBLAST; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; ANIMAL; BONE PROSTHESIS; CHEMISTRY; CYTOLOGY; METABOLISM; POROSITY;

ANIMALS; ANTIGENS, DIFFERENTIATION; BIOCOMPATIBLE MATERIALS; BONE SUBSTITUTES; EXTRACELLULAR MATRIX; GLASS; HUMANS; OSTEOBLASTS; POROSITY; SILICON;

EID: 84925109273     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.09.025     Document Type: Review

References (121)

1. Suess HE, Urey HC. Abundances of the elements. Rev Modern Phys 1956;28:53-74.
2. th ed. Upper Saddle River, NJ: Prentice Hall; 2000.
3. Bisse E, Epting T, Beil A, Lindinger G, Lang H, Wieland H. Reference values for serum silicon in adults. Anal Biochem 2005;337:130-5.
4. Yamaji N, Chiba Y, Mitani-Ueno N, Feng Ma J. Functional characterization of a silicon transporter gene implicated in silicon distribution in barley. Plant Physiol 2012;160:1491-7.
5. Marron AO, Alston MJ, Heavens D, Akam M, Caccamo M, Holland PW, et al. A family of diatom-like silicon transporters in the siliceous loricate choanoflagellates. Proc Biol Sci 2013;280:20122543.
6. Hildebrand M, Dahlin K, Volcani BE. Characterization of a silicon transporter gene family in Cylindrotheca fusiformis: sequences, expression analysis, and identification of homologs in other diatoms. Mol Gen Genet 1998;260:480-6.
7. Perry CC. An overview of silica in biology: its chemistry and recent technological advances. Prog Mol Subcell Biol 2009;47:295-313.
8. Giovine M, Scarfì S, Pozzolini M, Penna A, Cerrano C. Cell reactivity to different silica. Prog Mol Subcell Biol 2013;54:143-74.
9. Scarfì S, Benatti U, Pozzolini M, Clavarino E, Ferraris C, Magnone M, et al. Ascorbic acid-pretreated quartz enhances cyclo-oxygenase-2 expression in RAW 264.7 murine macrophages. FEBS J 2007;274:60-73.
10. Sripanyakorn S, Jugdaohsingh R, Thompson RPH, Powell JJ. Dietary silicon and bone health. Nutr Bull 2005;30:222-30.
11. Sripanyakorn S, Jugdaohsingh R, Elliott H, Walker C, Mehta P, Shoukru S, et al. The silicon content of beer and its bioavailability in healthy volunteers. Br J Nutr 2004;91:403-9.
12. Giammarioli S, Mosca M, Sanzini E. Silicon content of Italian mineral waters and its contribution to daily intake. J Food Sci 2005;70:501-12.
13. Jugdaohsingh R, Tucker KL, Qiao N, Cupples LA, Kiel DP, Powell JJ. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. J Bone Min Res 2004;19:297-307.
14. Jugdaohsingh R. Dietary silicon intake and absorption. Am J Clin Nutr 2002;75:887-93.
15. Martin KR. The chemistry of silica and its potential health benefits. J Nutr Health Aging 2007;11:94-7.
16. Pruska S, Siripinyanond A, Powell JJ, Jugdaosingh R. Silicon balance in human volunteers: a pilot study to establish the variance in silicon excretion versus intake. Nutr Metab 2014;11(4):1-9.
17. Iler R. The chemistry of silica. New York: Wiley; 1979.
18. Comb LF. Silica chemistry and reverse osmosis. Ultrapure Water 1996;13:41-3.
19. Kashutina IA, Potapov VV, Shulga OV, Sadovnikova AO, Kashpura VN, Gorbach VA, et al. In: Proceedings thirty-third workshop on geothermal reservoir engineering. Stanford University, Stanford, California; 2008.
20. th Saudi Engineering Conference 2002;2:3-14.
21. Schroder HC, Wang X, Tremel W, Ushijima H, Muller WEG. Biofabrication of biosilica-glass by living organisms. Nat Prod Rep 2008;25:455-74.
22. Lopez PJ, Coradin T. Biogenic silica patterning: simple chemistry or subtle biology. ChemBioChem 2003;3:1-9.
23. Carlisle EM. Silicon: an essential element for the chick. Science 1972;178: 619-21.
24. Carlisle EM. Silicon as an essential element. Fed Proc 1974;33:1758-66.
25. Carlisle EM. Silicon as a trace nutrient. Sci Total Environ 1988;73:95-106.
26. Schwarz K. A bound form of silicon in glycosaminoglycans and polyuronides. Proc Natl Acad Sci 1973;70:1608-12.
27. Carlisle EM. In vivo requirement for silicon in articular cartilage and connective tissue formation in the chick. J Nutr 1976;106:478-84.
28. Carlisle EM. Silicon. Nutr Rev 1975;33:257-61.
29. Landis WJ, Lee DD, Brenna JT, Chandra S, Morrison GH. Detection and localization of silicon and associated elements in vertebrate bone tissue by imaging ion microscopy. Calcif Tissue Int 1986;38:52-9.
30. Policard A, Collet A, Daniel Moussard H, Pregermain S. Deposition of silica in mitochondria: an electron microscopic study. J Biophys Biochem Cytol 1961;9:236-8.
31. Arumugam MQ, Ireland DC, Brooks RA, Rushton N, Bonfield W. Orthosilicic acid increases collagen type I mRNA expression in human bone-derived osteoblasts in vitro. Key Eng Mater 2006;254:869-72.
32. Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HRL, Evans BAJ, Thompson PRH, et al. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 2003;32:127-35.
33. Birchall JD, Espie AW. Biological implications of the interaction (via silanol groups) of silicon with metal ions. In: Evered D, O'Connor M, editors. Silicon biochemistry, Ciba foundation symposium 121. Chichester: John Wiley; 1986. p. 140-59.
34. Jugdaohsingh R, Reffitt DM, Oldham C, Day JP, Fifield LK, Thompson RP, et al. Oligomeric but not monomeric silica prevents aluminum absorption in humans. Am J Clin Nutr 2000;71:944-9.
35. Buchman AL, Howard LJ, Guenter P, Nishikawa RA, Compher CW, Tappenden KA. Micronutrients in parenteral nutrition: too little or too much? The past, present, and recommendations for the future. Gastroenterology 2009;137:S1-6.
36. Carlisle EM, Suchil C. Silicon and ascorbate interaction in cartilage formation in culture. Fed Proc 1983;42:398.
37. Fenoglio I, Martra G, Coluccia S, Fubini B. Possible role of ascorbic acid in the oxidative damage induced by inhaled crystalline silica particles. Chem Res Toxicol 2000;13:971-5.
38. Lia H, Changa J. Bioactive silicate materials stimulate angiogenesis in fibroblast and endothelial cell co-culture system through paracrine effect. Acta Biomater 2013;9:6981-91.
39. Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 2002;109:2384-97.
40. Mladenović Ž, Johansson A, Willman B, Shahabi K, Björn E, Ransjö M. Soluble silica inhibits osteoclast formation and bone resorption in vitro. Acta Biomater 2013;10:406-18.
41. Henstock JR, Ruktanonchai UR, Canham LT, Anderson SI. Porous silicon confers bioactivity to polycaprolactone composites in vitro. J Mater Sci Mater Med 2014;25:1087-97.
42. Landis WJ, Glimcher MJ. Electron diffractiona and electron probe microanalysis of the mineral phase of bone tissue prepared by anhydrous techniques. J Ultrastruct Res 1978;63:188-223.
43. Ratner BD, Hoffman AS, Schoen FJ, Lemons JE. Biomaterials science: an introduction to materials in medicine. New York: Academic Press; 2004.
44. Boivin G. The hydroxyapatite crystal: a closer look. Medicographia 2007;29:126-32.
45. Shepherd JH, Shepherd DV, Best SM. Substituted hydroxyapatites for bone repair. J Mater Sci Mater Med 2012;23:2335-47.
46. Birchall JD. The essentiality of silicon in biology. Chem Soc Rev 1995;24:351-7.
47. Elliot MA, Edwards HM. Effect of dietary silicon on growth and skeletal development in chickens. J Nutr 1991;121:201-7.
48. Hench LL. The story of Bioglass®. J Mater Sci - Mater Med 2006;17:967-78.
49. Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater 2013;9:4457-86.
50. Thomas MV, Puleo DA, Al-Sabbagh M. Bioactive glass three decades on. J Long Term Eff Med Implants 2005;15:585-97.
51. Lopez-Esteban A, Saiz E, Fujino S, Oku T, Suganuma K, Tomsia AP. Bioactive glass coatings for orthopaedic metallic implants. J Eur Ceram Soc 2003;23:2921-30.
52. Oliveira GM, Ferraz MP, González PG, Serra J, Leon B, Pèrez-Amor M, et al. PLD bioactive ceramic films: the influence of CaO-P2O5 glass additions to hydroxyapatite on the proliferation and morphology of osteoblastic like-cells. J Mater Sci - Mater Med 2008;19:1775-85.
53. Loty C, Sautier J-M, Boulekbache H, Kokubo T, Kim H-M. In vitro bone formation on a bone-like apatite layer prepares by a biomimetic process on a bioactive glass-ceramic. J Biomed Mater Res 1999;49:423-34.
54. Xynos IE, Alasdair JE, Buttery LDK, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5. J Biomed Mater Res 2001;55:151-7.
55. Gough JE, Downes S. Osteoblast cell death on methacrylate polymers involves apoptosis. J Biomed Mater Res, Part A 2001;15:497-505.
56. Valerio P, Pereira MM, Goes AM, Leite MF. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials 2004;25:2941-8.
57. Nakasaki M, Yoshioka K, Miyamoto Y, Sasaki T, Yoshikawa H, Itoh K. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone 2008;43:869-79.
58. Fiedler J, Röderer G, Günther KP, Brenner RE. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002;87:305-12.
59. Kaufmann EAB, Ducheyne P, Radin S, Bonnell DA, Composto R. Initial events at the bioactive glass surface in contact with protein-containing solutions. J Biomed Mater Res, Part A 2000;52:825-30.
60. Rosengren A, Oscarsson S, Mazzocchi M, Krajewski A, Ravaglioni A. Protein adsorption onto two bioactive glass-ceramics. Biomaterials 2003;24:147-55.
61. Misra SK, Mohn D, Brunner TJ, Stark WJ, Philip SE, Roy I, et al. Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites. Biomaterials 2008;29:1750-61.
62. Lobell KD, Hench LL. In vitro adsorption and activity of enzymes on reaction layers of bioactive glass substrates. J Biomed Mater Res, Part A 1998;39:575-9.
63. Manzano M, Lozano D, Arcos D, Portal-Núñez S, Orden CL, Esbrit P, et al. Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings. Acta Biomater 2011;7:3555-62.
64. Soderling E, Herbst K, Larmas E, Yli-Urpo A. Protein adsorption to a bioactive glass with special reference to precorrosion. J Biomed Mater Res, Part A 1996;31:525-31.
65. Anderson SI, Downes S, Perry CC, Caballero AM. Evaluation of the osteoblast response to a silica gel in vitro. J Mater Sci Mater Med 1998;9:731-5.
66. Li P, Nakanishi K, Kokubo T, de Groot K. Induction and morphology of hydroxyapatite, precipitated from metastable simulated body fluids on sol-gel prepared silica. Biomaterials 1993;14:963-8.
67. Rosenholm JM, Mamaeva V, Sahlgren C, Linden M. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage. Nanomedicine 2012;7(1):111-20.
68. Vivero-Escoto J, Huxford-Phillips R, Lin W. Silica-based nanoprobes for biomedical imaging and theranostic applications. Chem Soc Rev 2012;41(7):2673-85.
69. KwonS Singh RK, Perez RA, Neel EA, Kim HW, Chrzanowski W. Silica based mesoporous nanoparticles for controlled drug delivery. J Tissue Eng 2013;4. http://dx.doi.org/10.1177/2041731413503357.
70. Fubini B. Health effects of silica. In: Legrand, editor. Chapter 5 in the surface properties of silicas. Chichester: John Wiley; 1998.
71. Castanova V, Vallyathan V, Wallace WE. Silica and silica-induced lung diseases. Boca Raton, Florida: CRC Press; 1996.
72. IARC. International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Silica, some silicates coal dust and para-aramid fibrils, Vol. 68. Lyon: IARC; 1979. p. 210-211.
73. Canham LT. Properties of porous silicon. London: Inspec, IEE; 1997.
74. Feng ZC, Tsu R. Porous silicon. Singapore: World Scientific; 1994.
75. Nash KJ, Calcott PDJ, Cannham LT, Kane MJ, Brumhead D. The origin of efficient luminescence in highly porous silicon. J Lumin 1994;60-61:297-301.
76. Parkhutik V. Analysis of publications on porous silicon: from photoluminescence to biology. J Porous Mater 2000;7:363-6.
77. Canham LT. Bioactive silicon structure through nanoetching techniques. Adv Mater 1995;7:1033-7.
78. Halimaoui A Porous silicon formation by anodization. In: Canham, LT, editor. Properties of porous silicon. London: Institution of Engineering and Technology; 1997.
79. Seo YH, Nahm KS, An MH, Suh E-K, Lee YH, Lee KB, et al. Formation mechanism and pore size control of light-emitting porous silicon. J Appl Phys 1994;33:6425-31.
80. Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 2009;30:2440-8.
81. Zhang K, Loong SL, Connor S, Yu SW, Tan SY, Ng RT, et al. Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice. Clin Cancer Res 2005;11:7532-7.
82. Canham LT, Aston R. Will a chip every day keep the doctor away?'. Phys World 2001:27-31.
83. Jaganathan H, Godin B. Biocompatibility assessment of Si-based nano- and micro-particles. Adv Drug Deliv Rev 2012;64(15):1800-19.
84. Santos H. Porous silicon for biomedical applications. Cambridge: Woodhead Publishing; 2014. No. 68. p. 526.
85. Whitehead MA, Fan D, Mukherjee P, Akkaraju GR, Canham LT, Coffer JL. High-porosity poly(epsilon-caprolactone)/mesoporous silicon scaffolds: calcium phosphate deposition and biological response to bone precursor cells. Tissue Eng Part A 2008;14:195-206.
86. Johansson F, Kanje M, Linsmeier CE, Wallman L. The influence of porous silicon on axonal outgrowth in vitro. IEEE Trans Biomed Eng 2008;55:1447-9.
87. Alvarez SD, Derfus AM, Schwartz MP, Bhatia SN, Sailor MJ. The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors. Biomaterials 2008;30:26-34.
88. Shabir Q, Skaria C, O'Brien H, Loni A, Barnett C, Canham LT. Taste and mouthfeel assessment of porous and non-porous silicon microparticles. Nanoscale Res Lett 2012;7:407.
89. Low SP, Voelcker NH, Canham LT, Williams KA. The biocompatibility of porous silicon in tissues of the eye. Biomaterials 2009;30:2873-80.
90. Park JH, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 2009;8:331-6.
91. Shabir Q, Pokale A, Loni A, Johnson DR, Canham LT, Fenollosa R, et al. Medically biodegradable hydrogenated amorphous silicon microspheres. Silicon 2011. http://dx.doi.org/10.1007/s12633-011-9097-4.
92. Hwong et al. A physically transient form of electronics. Science 2012:1640-4.
93. Canham L. Nanosilicon for nanomedicine: a step towards biodegradable electronics ? Nanomedicine 2013;8(10):1-4.
94. Goosen JH, Kums AJ, Kollen BJ, Verheyen CC. Porous-coated femoral components with or without hydroxyapatite in primary uncemented total hip arthroplasty: a systematic review of randomized controlled trials. Arch Orthop Trauma Surg 2009;129:1165-9.
95. Bohner M. Silicon-substituted calcium phosphates-a critical view. Biomaterials 2009;30:6403-6.
96. Gibson IR, Best SM, Bonfield W. Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res 1999;44:422-8.
97. Thian ES, Huang J, Best SM, Barber ZH, Bonfield W. Silicon-substituted hydroxyapatite: The next generation of bioactive coatings. Mater Sci Eng, C 2007;27:251-6.
98. Zhang E, Zou C. Porous titanium and silicon-substituted hydroxyapatite biomodification prepared by a biomimetic process: characterization and in vivo evaluation. Acta Biomater 2009;5:1732-41.
99. Botelho CM, Brooks RA, Best SM, Lopes MA, Santos JD, Rushton N, et al. Human osteoblast response to silicon-substituted hydroxyapatite. J Biomed Mater Res, Part A 2006;79:723-30.
100. Rau JV, Foscaa M, Cacciottib I, Lauretic S, Biancob A, Teghild R. Nanostructured Si-substituted hydroxyapatite coatings for biomedical applications. Thin Solid Films 2013;543:167-70.
101. Arias JL, Mayor MB, Pou J, León B, Pérez-Amor M. Stoichiometric transfer in pulsed laser deposition of hydroxylapatite. Appl Surf Sci 2000;154:434-8.
102. Rau JV, Smirnov VV, Laureti S, Generosi A, Varvaro G, Fosca M, et al. Properties of pulsed laser deposited fluorinated hydroxyapatite films on titanium. Mater Res Bull 2010;45:1304-10.
103. Rau JV, Generosi A, Laureti S, Komlev VS, Ferro D, Cesaro SN, et al. Physicochemical investigation of pulsed laser deposited carbonated hydroxyapatite films on titanium. ACS Appl Mater Interfaces 2009;1:1813-20.
104. Leventouri T, Bunaciu CE, Perdikatsis V. Neutron powder diffraction studies of silicon-substituted hydroxyapatite. Biomaterials 2003;24:4205-11.
105. Marchat D, Zymelka M, Coelho C, Gremillard L, Joly-Pottuz L, Babonneau F, et al. Accurate characterization of pure silicon-substituted hydroxyapatite powders synthesized by a new precipitation route. Acta Biomater 2013;9:6992-7004.
106. Kim SR, Lee JH, Kim YT, Riu DH, Jung SJ, Lee SC, et al. Synthesis of Si, Mg substituted hydroxyapatites and their sintering behaviors. Biomaterials 2003;24:1389-98.
107. Reid JW, Pietak A, Sayer M, Dunfield D, Smith TJN. Phase formation and evolution in the silicon substituted tricalcium phosphate/apatite system. Biomaterials 2005;26:2887-97.
108. Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Effect of sintered silicate-substituted hydroxyapatite on remodelling processes at the bone-implant interface. Biomaterials 2004;25:3303-14.
109. Gibson IR, Best SM, Bonfield W. Effect of silicon substitution on the sintering and microstructure of hydroxyapatite. J Am Ceram Soc 2002;85:2771-7.
110. Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Comparison of in vivo dissolution processes in hydroxyapatite and silicon-substituted hydroxyapatite bioceramics. Biomaterials 2003;24:4609-20.
111. Janowsky EC, Kupper LL, Hulka BS. Meta-analysis of the relation between silicon breast implants and the risk of connected tissue diseases. N Eng J Med 2000;342(11):781-90.
112. Lugowksi SJ, Smith DC, Bonek H, Lugowski J, Peters W, Semple J. Analysis of silicon in human tissues with special reference to silicone breast implants. J Trace Elem Med Biol 2000;14:31-42.
113. Heublein B, Ozbek C, Pethig K. Silicon carbide-coated stents: clinical experience in coronary lesions with increased thrombotic risk. J Endovasc Surg 1998;5:32-6.
114. Anderson MC, Olsen R. Bone ingrowth into porous silicon nitride. J Biomed Mater Res 2010;92(4):1598-605.
115. Webster TJ, Patel AA, Rahaman MN, Sonny BB. Anti infective and osteointegration properties of silicon nitride, poly(ether ether ketone) and titanium implants. Acta Biomater 2012;8(12):4447-54.
116. Olofsson J, Grehk TM, Berlind T, Persson C, Jacobson S, Engqvist H. Evaluation of silicon nitride as a wear resistant and resorbable alternative for total hip joint replacement. Biomatter 2012;2(2):1-9.
117. Thomas MV, Puleo DA, Al-Sabbagh. Bioactive glass three decades on. J Long Term Eff Med Implants 2005;15:585-97.
118. Mahony O, Jones JR. Porous bioactive nanostructured scaffolds for bone regeneration: a sol-gel solution. Nanomedicine (Lond) 2008;3:233-45.
119. Mahony O, Tsigkou O, Ionescu C, Minelli C, Ling L, Hanly R, et al. Silica-gelatin hybrids with tailorable degradation and mechanical properties for tissue regeneration. Adv Funct Mater 2010;20:3835-45.
120. Sachot N, Castaño O, Mateos-Timoneda MA, Engel E, Planell JA. Hierarchically engineered fibrous scaffolds for bone regeneration. J R Soc Interface 2013;10:20130684.
121. Castaño O, Sachot N, Xuriguera E, Engel E, Planell JA, Park JH, et al. Angiogenesis in bone regeneration: tailored calcium release in hybrid fibrous scaffolds. ACS Appl Mater Interfaces 2014;6:7512-22.